Cargando…

Soluble factors and suppressive monocytes can predict early development of sepsis in acute‐on‐chronic liver failure

Patients with acute‐on‐chronic liver failure (ACLF) have a high probability of developing systemic inflammation and sepsis due to immune dysregulation. Fifty‐nine patients with ACLF (12 without and 19 with systemic inflammation, and 28 with sepsis) were serially monitored for clinical and immunologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yadav, Pushpa, Trehanpati, Nirupama, Maiwall, Rakhi, Sehgal, Rashi, Singh, Ravinder, Islam, Mojahidul, Jagdish, Rakesh Kumar, Vijayaraghavan, Rajan, Maheshwari, Deepanshu, Bhat, Sadam, Kale, Pratibha, Kumar, Anupam, Baweja, Sukriti, Kumar, Guresh, Ramakrishna, Gayatri, Sarin, Shiv K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315131/ https://www.ncbi.nlm.nih.gov/pubmed/35502507 http://dx.doi.org/10.1002/hep4.1949

Ejemplares similares

Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis
por: Sehgal, Rashi, et al.
Publicado: (2022)

Bioenergetic Failure Drives Functional Exhaustion of Monocytes in Acute-on-Chronic Liver Failure
por: Maheshwari, Deepanshu, et al.
Publicado: (2022)

miRNA signatures can predict acute liver failure in hepatitis E infected pregnant females
por: Trehanpati, Nirupma, et al.
Publicado: (2017)

Plasma Proteomic Analysis Identified Proteins Associated with Faulty Neutrophils Functionality in Decompensated Cirrhosis Patients with Sepsis
por: Sehgal, Rashi, et al.
Publicado: (2022)

Sustained expression of inflammatory monocytes and activated T cells in COVID‐19 patients and recovered convalescent plasma donors
por: Singh, Ravinder, et al.
Publicado: (2021)

SARS-Cov-2 (human) and COVID-19: Primer 2020
por: Ramakrishna, Gayatri, et al.
Publicado: (2020)

Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis
por: Kaur, Savneet, et al.
Publicado: (2021)

Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN
por: Islam, Mojahidul, et al.
Publicado: (2023)

Iron-Overload triggers ADAM-17 mediated inflammation in Severe Alcoholic Hepatitis
por: Maras, Jaswinder Singh, et al.
Publicado: (2018)

Case Control Study of Post-endoscopic Variceal Ligation Bleeding Ulcers in Severe Liver Disease: Outcomes and Management
por: Jamwal, Kapil D., et al.
Publicado: (2019)

Evaluation of the Integrative Weaning Index for Predicting the Outcome of Spontaneous Breathing Trial in Patients with Cirrhosis on Mechanical Ventilation: A Pilot Study
por: Sahu, Shailesh, et al.
Publicado: (2022)

Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury
por: Bhatia Kapoor, Puja, et al.
Publicado: (2023)

Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients
por: Vijayaraghavan, Rajan, et al.
Publicado: (2021)

Alcohol associated liver cirrhotics have higher mortality after index hospitalization: Long-term data of 5,138 patients
por: Jain, Priyanka, et al.
Publicado: (2021)

Maternal Immunity Influences Vertical Transmission of Hepatitis B to Newborns
por: Vyas, Ashish Kumar, et al.
Publicado: (2019)

Emerging Role of Edible Exosomes-Like Nanoparticles (ELNs) as Hepatoprotective Agents
por: Subudhi, P. Debishree, et al.
Publicado: (2022)

Identifying critically ill patients with cirrhosis who benefit from nutrition therapy: the mNUTRIC score study
por: Tripathi, Harshita, et al.
Publicado: (2022)

Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)
por: Bajpai, Meenu, et al.
Publicado: (2022)

CD4+CD25+CD127(low) Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Sharma, Shreya, et al.
Publicado: (2015)

Degree of Portal and Systemic Hemodynamic Alterations Predict Recurrent AKI and Chronic Kidney Disease in Patients With Cirrhosis
por: Maiwall, Rakhi, et al.
Publicado: (2020)

EpCAM+ Liver Cancer Stem‐Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic Patients
por: Khosla, Ritu, et al.
Publicado: (2017)

EUS-guided Gall Bladder Drainage in Severe Liver Disease: A Single-center Experience in Critically Ill Cirrhotics
por: Jamwal, Kapil Dev, et al.
Publicado: (2017)

Hepatic Arterioportal Fistula in Patients with Cirrhosis with Endovascular Management—A Series of 4 Cases with Review of Literature
por: Chandel, Karamvir, et al.
Publicado: (2022)

Tracheostomy in critically ill liver disease patients with coagulopathy: A retrospective study at a tertiary center
por: Saluja, Vandana, et al.
Publicado: (2020)

Efficacy and safety of an open lung ventilation strategy with staircase recruitment followed by comparison on two different modes of ventilation, in moderate ARDS in cirrhosis: A pilot randomized trial
por: Vibha, Goel, et al.
Publicado: (2021)

Suboptimal Level of Bone‐Forming Cells in Advanced Cirrhosis are Associated with Hepatic Osteodystrophy
por: Bihari, Chhagan, et al.
Publicado: (2018)

Hyperoxidized Albumin Modulates Platelets and Promotes Inflammation Through CD36 Receptor in Severe Alcoholic Hepatitis
por: Bhat, Adil, et al.
Publicado: (2019)

P141 Study of prevalence, antifungal profile and predictors of mortality in chronic pulmonary Aspergillosis in a cohort of liver disease patient
por: Kale, Pratibha, et al.
Publicado: (2022)

P406 Rise in HIV negative Cryptococcal infection in liver disease patient: epidemiology, risk factor, antifungal susceptibility profile from tertiary care hepatobiliary center
por: Patel, Dhruvi, et al.
Publicado: (2022)

P409 Study of epidemiology, risk factors and antifungal sensitivity pattern of fungal pneumonia in critically ill cirrhotics
por: Singh, Paras, et al.
Publicado: (2022)

P438 Epidemiology, risk factor analysis and management of invasive Candida auris infections in tertiary care hepatobiliary center in India
por: Patel, Niharika, et al.
Publicado: (2022)

Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial
por: Sharma, Manoj Kumar, et al.
Publicado: (2019)

Role of Microbiota in Pathogenesis and Management of Viral Hepatitis
por: Sehgal, Rashi, et al.
Publicado: (2020)

CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis
por: Bihari, Chhagan, et al.
Publicado: (2022)

2305. Incidence of Active Cytomegalovirus Infection and Its Influence on Outcome Among Non-Immunosuppressed Cirrhotic Adults Requiring Critical Care in Liver-ICU
por: Shah, Dhara B, et al.
Publicado: (2019)

Prevention and Treatment of Recurrent Hepatitis B after Liver Transplantation
por: Maiwall, Rakhi, et al.
Publicado: (2016)

Diagnostic efficacy of dynamic liver imaging using qualitative diagnostic algorithm versus LI-RADS v2018 lexicon for atypical versus classical HCC lesions: A decade of experience from a tertiary liver institute
por: Laroia, Shalini Thapar, et al.
Publicado: (2020)

Material decomposition using iodine quantification on spectral CT for characterising nodules in the cirrhotic liver: a retrospective study
por: Laroia, Shalini Thapar, et al.
Publicado: (2021)

Differential blood transcriptome modules predict response to corticosteroid therapy in alcoholic hepatitis
por: Sharma, Shvetank, et al.
Publicado: (2021)

A randomized open label trial of tenofovir monotherapy versus tenofovir plus telbivudine in spontaneous reactivation of hepatitis B
por: Jindal, Ankur, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bre46h2ul5rr295jp19j7pg6l4